Preferred Name |
travoprost |
|
Synonyms |
propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoate Travoprost isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate travoprostum Travatan Travatan Z travoprost |
|
Definitions |
The isopropyl ester of prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of travoprost are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. It is a pro-drug; the isopropyl ester group is hydrolysed by esterases in the cornea to the biologically active free acid, fluprostenol. |
|
ID |
http://purl.obolibrary.org/obo/CHEBI_746859 |
|
charge |
0 |
|
database_cross_reference |
DrugBank:DB00287 Reaxys:8739060 KEGG:D01964 Wikipedia:Travoprost HMDB:HMDB0014432 PMID:22259229 PMID:22167541 PMID:22050687 Drug_Central:2716 CAS:157283-68-6 |
|
formula |
C26H35F3O6 |
|
has functional parent | ||
has role |
http://purl.obolibrary.org/obo/CHEBI_39456 http://purl.obolibrary.org/obo/CHEBI_66900 http://purl.obolibrary.org/obo/CHEBI_66981 |
|
has_exact_synonym |
propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoate Travoprost |
|
has_obo_namespace |
chebi_ontology |
|
has_related_synonym |
isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate travoprostum Travatan Travatan Z travoprost |
|
has_RxCUI |
283809 |
|
id |
CHEBI:746859 |
|
in_subset | ||
inchi |
InChI=1S/C26H35F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,19,21-24,30-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t19-,21-,22-,23+,24-/m1/s1 |
|
inchikey |
MKPLKVHSHYCHOC-AHTXBMBWSA-N |
|
label |
travoprost |
|
mass |
500.54770 |
|
monoisotopicmass |
500.23857 |
|
notation |
CHEBI:746859 |
|
prefixIRI |
CHEBI:746859 |
|
prefLabel |
travoprost |
|
smiles |
CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COc1cccc(c1)C(F)(F)F |
|
textual definition |
The isopropyl ester of prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of travoprost are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. It is a pro-drug; the isopropyl ester group is hydrolysed by esterases in the cornea to the biologically active free acid, fluprostenol. |
|
subClassOf |
http://purl.obolibrary.org/obo/CHEBI_35725 |